Annette Bode, ARNP, is the Medical Director at Weight Method (weightmethod.com), a telehealth platform prescribing FDA-approved GLP-1 medications for weight loss. With extensive clinical experience in medical weight management, she oversees patient evaluations, treatment protocols, and dosage titration for semaglutide and tirzepatide prescriptions. Annette specializes in obesity medicine, metabolic health, and evidence-based weight loss interventions. She provides personalized care to 47,000+ members across all 50 states through telehealth consultations, ensuring safe and effective GLP-1 treatment outcomes. Based in Miami, FL, she also supports in-person GLP-1 treatments at Weight Method's physical clinic.